Accrosuv 10 Tablet
Marketer
Accilex Diacardo
Salt Composition
Rosuvastatin (10mg)
Overview Accrosuv 10 Tablet
Lipitor-Equiv 10mg tablets are statin-class medications employed to decrease cholesterol and mitigate the risk of cardiovascular events. High cholesterol, a fatty substance accumulating in blood vessels, causes narrowing that can result in stroke or heart attack. This widely prescribed medication is considered safe for prolonged use and can be administered with or without food, consistently at the same time daily. While elevated cholesterol often presents no symptoms, discontinuation increases cholesterol levels, worsening the condition and raising the risk of heart disease and stroke. Regular cholesterol monitoring is vital. Treatment involves this medication alongside a healthy diet, regular physical activity, smoking cessation, controlled alcohol consumption, and weight management. Maintain a normal diet, minimizing high-fat foods. Common, typically transient, side effects include muscle aches, weakness, nausea, headache, and stomach upset. Persistent symptoms, jaundice, or recurring unexplained muscle pain necessitate medical attention. Contraindicated in liver disease, pregnancy, and breastfeeding due to potential fetal harm. Diabetics should monitor blood glucose levels as this medication may elevate them.
Uses of Accrosuv 10 Tablet
Managing hyperlipidemia to reduce cardiovascular event risk.
Major Benefits of Accrosuv 10 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Accrosuv 10 Tablet. Ingest the tablet whole; avoid chewing, crushing, or breaking it. While it can be taken with or without food, consistent timing is recommended.
Common Side effects of Accrosuv 10 Tablet:
- Muscle pain
- Weakness
- Headache
- Abdominal pain
- Dizziness
- Joint pain
- Nausea
How to use Accrosuv 10 Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Accrosuv 10 Tablets can be taken with or without food, although consistent timing is recommended.
How Accrosuv 10 Tablet works:
A single Accrosuv 10 Tablet, a statin-class drug, reduces lipid levels by inhibiting HMG-CoA reductase, the enzyme responsible for cholesterol synthesis. This action decreases low-density lipoprotein ("bad" cholesterol) and triglycerides while increasing high-density lipoprotein ("good" cholesterol).
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Accrosuv 10 Tablet concurrently with alcohol. Seek medical advice.
PregnancyUNSAFE
Use of Accrosuv 10 Tablet is strongly contraindicated during pregnancy. Pregnant women should consult their physician; research in animals and pregnant humans indicates substantial risks to fetal development.
Breast feedingUNSAFE
Lactation and Accrosuv 10 Tablet are incompatible. Evidence indicates potential infant harm from this medication.
DrivingSAFE
Driving ability is typically unaffected by Accrosuv 10 Tablet.
KidneyCAUTION
Patients with kidney impairment should use Accrosuv 10 Tablet cautiously, potentially requiring dosage modification under medical supervision. Avoid Accrosuv 10 Tablet if you have severely compromised kidney function. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Accrosuv 10 Tablet cautiously, potentially requiring dosage modification under medical supervision. The medication is contraindicated for individuals with severe or active liver disease.
What if you forget to take Accrosuv 10 Tablet :
Should you forget to take a dose of Accrosuv 10 Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking consecutive doses within a 12-hour period.
Facts to Know About Accrosuv 10 Tablet
| Label | Value |
|---|---|
| Type of Compound | Compounds derived from phenylpyrimidine |
| Addictive | None. |
| Medication Classification | HEART |
| Mechanism of Action | 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors |


